NEU:ASX
Neuren Pharmaceuticals Ltd
A$20.66
arrow_downward
-0.43%(-0.090) 1D
Nov 3, 4:10:15 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$20.80
High
A$21.08
Low
A$20.08
Mkt. cap
2.62B
Avg. vol.
327.78K
Volume
378.65K
Dividend
0.73%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
133.83
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
Open
A$20.80
High
A$21.08
Low
A$20.08
Mkt. cap
2.62B
Avg. vol.
327.78K
Volume
378.65K
Dividend
0.73%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
133.83
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
News stories
From web sources and news partners
FinancialContent
·
1 hour ago
Yum China (NYSE:YUMC) misses Q3 2026 sales expectations
The Chronicle-Journal
·
15 minutes ago
Amneal (NASDAQ:AMRX) beats expectations in strong Q3 2026, full-year outlook slightly exceeds expectations
The Motley Fool
·
25 minutes ago
The S&P 500's Record Profits Are Hiding a Problem Investors Haven't Seen Before
Barron's
·
1 hour ago
Stocks That Explain Today’s Market
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com